Open-House Discount Contracts for Infliximab (Subcutaneous Injection)
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-10 - Infliximab (Darreichungsform zur subkutanen Injektion)
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
30 / 100
Risk factors
No estimated contract value, framework maximum value, or budget provided. Revenue potential is unknown.
Contract ends automatically upon patent expiry or loss of market exclusivity. Could be terminated earlier than the max...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until May 2028
- Conclusion of discount contracts for Infliximab (subcutaneous injection) with multiple pharmaceutical entrepreneurs.
- Uniform contract terms; no individual negotiations.
Show full summary
Open-House procedure for discount contracts (Rabattverträge) under § 130a Abs. 8 SGB V for the active substance Infliximab (subcutaneous injection). No competitive selection; any qualified pharmaceutical entrepreneur can join. No estimated value provided. The lead buyer is Techniker Krankenkasse, with several other German statutory health insurance funds. The contract term is up to 24 months starting June 1, 2026, ending May 31, 2028. Participation is open throughout the contract term. No procurement documents were analyzed.
Risks
No estimated contract value, framework maximum value, or budget provided. Revenue potential is unknown.
Contract ends automatically upon patent expiry or loss of market exclusivity. Could be terminated earlier than the max...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
- Must hold a valid marketing authorization for the product or be entitled to place the product on the market.
Administrative
- Must provide a self-declaration on authorization and company (Anlage 4).
Requirements may be incomplete.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-House Discount Contracts for Infliximab (Subcutaneous Injection)
Conclusion of discount contracts for the active substance Infliximab (subcutaneous injection) with any eligible pharmaceutical entrepreneur under an open-house model. No exclusivity; uniform conditions apply.
Location
Duration
Category
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Infliximab (Darreichungsform zur subkutanen Injektion) im Rahmen eines Open-House-Verfahrens.
Value note
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2026-10 - Infliximab (Darreichungsform zur subkutanen Injektion)
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Infliximab (Darreichungsform zur subkutanen Injektion) im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 19 Apr 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 266368-2026
Documents (1)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
30 / 100
Risk factors
No estimated contract value, framework maximum value, or budget provided. Revenue potential is unknown.
Contract ends automatically upon patent expiry or loss of market exclusivity. Could be terminated earlier than the max...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications